Clinical Trials Logo

Clinical Trial Summary

His-Ventricle (HV) measurement is only obtained invasively using transvenous catheters. This kind of procedure is routinely performed but some risks of complication exist. HV interval prolongation is correlated with increased risk of occurrence of complete atrioventricular block which could lead to syncope or cardiac sudden death. A new non invasive, high density and high fidelity system (BioSemi, BioSemi B.V., Amsterdam, Netherlands) can theorically collect such electrophysiological signal using a signal averaging acquisition method. We want to assess the possibility of non invasive HV interval measurement using this new device.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04138797
Study type Interventional
Source University Hospital, Bordeaux
Contact
Status Completed
Phase N/A
Start date October 7, 2019
Completion date January 27, 2021

See also
  Status Clinical Trial Phase
Completed NCT05329246 - Validation of PMcardio AI-assisted Clinical Assistant in Primary Care N/A
Active, not recruiting NCT05872945 - Model-based Systems for Professional Football Teams, Aimed at Optimizing Health and Performance
Enrolling by invitation NCT04221958 - Surface ECG Mapping
Recruiting NCT06383546 - Artificial Intelligence-enabled ECG Detection of Congenital Heart Disease in Children: a Novel Diagnostic Tool
Recruiting NCT05777083 - A Trial for the Earlier Diagnosis of Inferior Wall STEMI Using a Six-lead Handheld EKG Recorder N/A
Recruiting NCT06285084 - Deep Learning ECG Evaluation and Clinical Assessment for Competitive Sport Eligibility
Recruiting NCT04981626 - Interoception in Anorexia Nervosa
Completed NCT05425342 - iECG: Recording Chest Leads Using a Smartwatch With a Digital Image Processing Algorithm N/A